Phase @ , randomized , double-blind , placebo-controlled , dose-ranging study conducted from June @ to June @ among @ patients aged @ years or older who were diagnosed as having CDI ( first episode or first recurrence ) and had successfully completed treatment with metronidazole , oral vancomycin , or both at @ study centers in the United States , Canada , and Europe .